IFP Advisors’s Verona Pharma VRNA Stock Holding History

IFP Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-399	Closed	-$42.6K	–	5049
2025 Q3	$42.6K	Sell	399 -148	-27%	-$15.5K	﹤0.01%	2163
2025 Q2	$51.7K	Buy	+547	New	+$40.5K	﹤0.01%	2029
2023 Q2	–	Sell	-50	Closed	-$832	–	3580
2023 Q1	$832	Buy	+50	New	+$1.08K	﹤0.01%	3112

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors's VRNA Position: Q4 2025 in Review

IFP Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 399 shares — an estimated $42.6K sold.

IFP Advisors first reported a position in VRNA in Q1 2023 and held it in 3 quarters. The position peaked at $51.7K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

IFP Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
IFP Advisors sold 399 Verona Pharma shares in Q4 2025, an estimated $42.6K.
IFP Advisors first reported a position in Verona Pharma in Q1 2023 and held it in 3 quarters.
IFP Advisors's Verona Pharma position peaked at $51.7K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.